Carrier Drug Development Incubation And

CHAMRAY

Carrier Drug Development Incubation And

Industrial Development Of Macromolecular Biopharmaceuticals

From DNA to IND

Concentric Health

CHAMRAY

Concentric Health


TECHNICAL SERVICE PROJECT


ABOUT CHAMRAY


CHAMRAY Biotechnology (Chengdu) Co., Ltd. (hereinafter referred to as "CHAMRAY Bio") was established in Chengdu Tianfu International Bio-city in 2021. It was established by the national high-tech enterprise Chengdu Yuanrui Biology and the top 100 listed pharmaceutical group. Composed of a team of immunology scientists and a team of senior engineers in biopharmaceutical development, it has 7 invention patents (patent numbers: 2013103629218, 201410192532X, 2015107720050, 2015107787671, 2017100592845, 2017109708141, 2018101777152) and is the first "carrier with new drug export capabilities" in the west.

profile

NEWS


Macromolecular Biopharmaceutical Research*

Chengdu Tianfu International Biocity was awarded the license and recognized Changrui Biotech as the "public technology platform for carrier drug development and macromolecular biodrug research" in Biocity.

Changrui Biologics - a public technical service platform for vector drug development and macromolecular biopharmaceutical research

On March 29, 2022, Changrui Biotechnology (Chengdu) Co., Ltd. (hereinafter referred to as "Changrui Biotechnology") was awarded the license by Chengdu Tianfu International Biocity, and recognized Changrui Biotechnology as the "public technology platform for carrier drug development and macromolecule biodrug research" in Biocity.

Changrui Biotech participated in the 2022 college campus job fair

On June 2, 2022, invited by the Administrative Committee of Chengdu Tianfu International Biocity, Changrui Biotech participated in the "Chengdu Tianfu International Biocity 2022 College Campus Special Job Fair" held at Southwest University for Nationalities.

More